drugset / Trial / NCT05019326

Andrographis Paniculata vs Boesenbergia Rotunda vs Control in Asymptomatic COVID-19

NCT05019326 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to examine the effect of Andrographis Extract, Boesenbergia Extract compared to standard treatment in asymptomatic COVID patients.

Timeline

Start
2021-08-30
Primary completion
2022-05-30
Completion
2022-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Andrographis Paniculata Traditional medicine (herbal / TCM) 180 mg —
Subject Boesenbergia Unknown 180 mg —

Indications